
Share
Archelle Georgiou, a healthcare insider, reveals the hidden motives driving insurance companies' use of prior authorization, offering fresh insights into why these hurdles exist and their real-world consequences for patient care.
When it comes to healthcare, few practices are as frustrating and opaque as prior authorization. This process requires doctors to get insurance approval before prescribing certain treatments or medications, often leading to delays and denials that can seriously impact patient care. A recent interview with Archelle Georgiou, a former United Healthcare executive, sheds new light on the real goals behind this controversial practice.
For patients, prior authorization can be a bureaucratic nightmare. Imagine you’re dealing with a chronic condition like diabetes or cancer, and your doctor prescribes a medication that could significantly improve your quality of life. Instead of starting treatment immediately, you find yourself caught in a web of paperwork and phone calls, waiting for an insurance company to decide whether you deserve the care your doctor believes is necessary.
This delay can be more than just inconvenient; it can have serious health consequences. Patients may lose faith in their healthcare providers, or worse, their conditions may worsen while they wait for approval. Georgiou, who has been on both sides of this issue, understands these frustrations intimately.
Georgiou’s experience at United Healthcare, now the largest health insurance company in the country, gives her a unique perspective. She played a role in implementing and later reforming prior authorization policies. According to her, the primary goal of prior authorization is not always to ensure that patients receive the best care but often to control costs.
“The denial is the outcome,” Georgiou explained. “Insurers use prior authorization as a tool to manage expenses, sometimes at the expense of patient well-being.”
To understand why this practice can be so problematic, it helps to break down how it works. When a doctor prescribes a treatment that requires prior authorization, they must submit detailed information to the insurance company, explaining why the treatment is necessary. The insurer then reviews the request and decides whether to approve or deny it.
This process can take days or even weeks, during which time patients are left in limbo. If the request is denied, the doctor may have to appeal the decision, further delaying care. Georgiou points out that this system often benefits insurers by reducing the number of expensive treatments they must cover.

The frustration with prior authorization has not gone unnoticed. Congress and state legislatures are increasingly taking steps to reform the practice. For example, some states have passed laws requiring insurance companies to provide faster responses to prior authorization requests or limiting the types of treatments that can be subject to this process.
However, Georgiou warns that these reforms often fall short of addressing the root causes. “Real change will require a fundamental shift in how we approach healthcare financing,” she said. “We need to prioritize patient outcomes over cost savings.”
While controlling healthcare costs is essential, it should not come at the expense of patients’ health. Georgiou suggests that one way to achieve this balance is through more transparent and evidence-based decision-making. For instance, insurers could use clinical guidelines developed by medical experts to guide their prior authorization decisions.
Additionally, greater collaboration between insurers, healthcare providers, and patient advocates could help create a system that better serves everyone’s interests. “We need to work together to find solutions that ensure patients get the care they need while also managing costs effectively,” Georgiou emphasized.
The debate over prior authorization is far from over. As policymakers continue to grapple with this issue, it’s crucial to keep the human impact at the forefront of discussions. Patients deserve a healthcare system that prioritizes their well-being and provides timely access to necessary treatments.
For now, Georgiou’s insights offer a valuable perspective on why prior authorization remains such a contentious issue in healthcare. By understanding the motivations behind these policies, we can work towards more equitable and effective solutions.
Tags
Original Sources
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
30 April 2026
133 articles
Related Articles
Related Articles
More Stories